Value of high-dose cytarabine during interval therapy of a Berlin-Frankfurt-Munster-based protocol in increased-risk children with acute lymphoblastic leukemia and lymphoblastic lymphoma: results of the European Organization for Research and Treatme (Q43562717)
Jump to navigation
Jump to search
scientific article published in April 2001
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Value of high-dose cytarabine during interval therapy of a Berlin-Frankfurt-Munster-based protocol in increased-risk children with acute lymphoblastic leukemia and lymphoblastic lymphoma: results of the European Organization for Research and Treatme |
scientific article published in April 2001 |
Statements
1 reference
Value of high-dose cytarabine during interval therapy of a Berlin-Frankfurt-Munster-based protocol in increased-risk children with acute lymphoblastic leukemia and lymphoblastic lymphoma: results of the European Organization for Research and Treatme (English)
1 reference
F Millot
1 reference
S Suciu
1 reference
N Philippe
1 reference
Y Benoit
1 reference
F Mazingue
1 reference
A Uyttebroeck
1 reference
P Lutz
1 reference
F Mechinaud
1 reference
A Robert
1 reference
P Boutard
1 reference
G Marguerite
1 reference
A Ferster
1 reference
E Plouvier
1 reference
X Rialland
1 reference
C Behard
1 reference
D Plantaz
1 reference
M F Dresse
1 reference
P Philippet
1 reference
L Norton
1 reference
A Thyss
1 reference
N Dastugue
1 reference
C Waterkeyn
1 reference
E Vilmer
1 reference
J Otten
1 reference
Children's Leukemia Cooperative Group of the European Organiztaion for Research and Treatment of Cancer
1 reference
1 April 2001
1 reference
1 reference
Identifiers
1 reference